{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:37Z","timestamp":1792425757723,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,25]]},"DOI":"10.1093\/eurheartj\/ehad403","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T14:53:11Z","timestamp":1687704791000},"page":"2135-2139","source":"Crossref","is-referenced-by-count":9,"title":["Challenges and opportunities in the management of acute heart failure and cardiac amyloidosis"],"prefix":"10.1093","volume":"44","author":[{"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome , Italy"},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,25]]},"reference":[{"key":"2023062514530906900_ehad403-B1","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/ehad266","article-title":"Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice","volume":"44","author":"Mullens","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/eurheartj\/ehac784","article-title":"Time to revisit combination loop and thiazide diuretic therapy for patients with acute heart failure","volume":"44","author":"Zakeri","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B3","first-page":"908","article-title":"The Cardiology Society of India\u2013Kerala Acute Heart Failure Registry: poor adherence to guideline-directed medical therapy","volume":"43","author":"Joseph","year":"2022","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B4","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1093\/eurheartj\/ehab620","article-title":"Compensatory post-diuretic renal sodium reabsorption is not a dominant mechanism of diuretic resistance in acute heart failure","volume":"42","author":"Cox","year":"2021","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B6","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1093\/eurheartj\/ehab360","article-title":"Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Lam","year":"2021","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurheartj\/ehaa968","article-title":"Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Packer","year":"2021","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurheartj\/ehaa1007","article-title":"Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Butler","year":"2021","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehab092","article-title":"Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial","volume":"42","author":"Marx","year":"2021","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehab094","article-title":"Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial","volume":"42","author":"Heerspink","year":"2021","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B11","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/eurheartj\/ehad276","article-title":"Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER","volume":"44","author":"Butt","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B12","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/eurheartj\/ehad315","article-title":"Good for your heart and safe for your toes: a patient-level meta-analysis of DAPA-HF and DELIVER","volume":"44","author":"Arnott","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B13","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1093\/eurheartj\/ehac526","article-title":"The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment response","volume":"43","author":"Damy","year":"2022","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B14","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B15","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1093\/eurheartj\/ehac259","article-title":"Characteristics and natural history of early-stage cardiac transthyretin amyloidosis","volume":"43","author":"Law","year":"2022","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B16","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/eurheartj\/ehad139","article-title":"Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis","volume":"44","author":"Rauf","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B17","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/eurheartj\/ehad281","article-title":"Expanding indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy","volume":"44","author":"Dorbala","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B18","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/eurheartj\/ehad210","article-title":"Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial","volume":"44","author":"Tolomeo","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B19","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/eurheartj\/ehad284","article-title":"Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure","volume":"44","author":"Damman","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B20","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/eurheartj\/ehad273","article-title":"Sodium\u2013glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study","volume":"44","author":"Fu","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B21","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/eurheartj\/ehad282","article-title":"SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B22","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1093\/eurheartj\/ehac481","article-title":"Dapagliflozin for heart failure according to body mass index: the DELIVER trial","volume":"43","author":"Adamson","year":"2022","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B23","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/eurheartj\/ehac495","article-title":"Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme","volume":"43","author":"Zannad","year":"2022","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B24","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/eurheartj\/ehac320","article-title":"Uric acid and sodium\u2013glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial","volume":"43","author":"Doehner","year":"2022","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B25","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/eurheartj\/ehad339","article-title":"COVID-19 vaccination-related myocarditis: a Korean nationwide study","volume":"44","author":"Cho","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B26","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/eurheartj\/ehad274","article-title":"Takotsubo syndrome is a coronary microvascular disease: experimental evidence","volume":"44","author":"Dong","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B27","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/eurheartj\/ehad264","article-title":"Is Takotsubo syndrome just the tip of the iceberg in the clinical spectrum of coronary microvascular dysfunction?","volume":"44","author":"Candreva","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B28","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad286","article-title":"To screen or not to screen: that is the question!","volume":"44","author":"Hansen","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/eurheartj\/ehad017","article-title":"Value of screening for the risk of sudden cardiac death in young competitive athletes","volume":"44","author":"Sarto","year":"2023","journal-title":"Eur Heart J"},{"key":"2023062514530906900_ehad403-B30","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/eurheartj\/ehad288","article-title":"Pre-participation screening for safe sports activity","volume":"44","author":"Corrado","year":"2023","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/24\/2135\/50699820\/ehad403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/24\/2135\/50699820\/ehad403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:18:01Z","timestamp":1702667881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/24\/2135\/7207426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":30,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,6,25]]},"published-print":{"date-parts":[[2023,6,25]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehad403","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6,21]]},"published":{"date-parts":[[2023,6,21]]}}}